Nan Hsuan Wang

Title: The Innovations of Nan Hsuan Wang

Introduction

Nan Hsuan Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of adjuvants for vaccines. His work is characterized by a focus on enhancing the efficacy of immunological responses through innovative methods.

Latest Patents

Wang holds a patent for a "Saponin adjuvant and evaluation method thereof." This patent involves six isomer structures of the isolated OBI-821 adjuvant, specifically OBI-821-1990-V1A, OBI-821-1990-V1B, OBI-821-1990-V2A, OBI-821-1990-V2B, OBI-821-1858-A, and OBI-821-1858-B. The method for evaluating the quality of this adjuvant utilizes hydrophilic interaction liquid chromatography (HILIC) and reverse phase high performance liquid chromatography (RP-HPLC). This innovative approach allows for the effective separation of the isomers of OBI-821 adjuvant, thereby facilitating a more accurate evaluation of its quality.

Career Highlights

Wang is currently associated with Obi Pharma Inc., where he continues to advance his research and development efforts. His work at the company has positioned him as a key player in the pharmaceutical industry, particularly in the area of vaccine adjuvants.

Collaborations

Wang has collaborated with notable colleagues, including Cheng-Der Tony Yu and Yih-Huang Hsieh. These partnerships have contributed to the advancement of his research and the successful development of innovative solutions in the field.

Conclusion

Nan Hsuan Wang's contributions to the field of pharmaceuticals, particularly through his patent on saponin adjuvants, highlight his innovative spirit and dedication to improving vaccine efficacy. His work continues to influence the industry and pave the way for future advancements.